IDKOY yields 1.09% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, IDKOY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of IDKOY + PFE for your $10,000?
Idemitsu Kosan Co.,Ltd. operates in petroleum, basic chemicals, functional materials, power and renewable energy, and resources businesses in Japan and internationally. The company's Petroleum segment engages in the procurement of crude oil and refining of petroleum products; sale of gasoline, diesel oil, kerosene, automotive lubricants, industrial kerosene, heavy oil, and aviation and marine fuel; and operation of hydrogen stations. Its Basic Chemicals segment manufactures and sells olefins, such as ethylene, propylene, and butadiene; aromatics, including benzene, styrene monomer, mixed xylene, and paraxylene; and other chemicals. The company's Functional Materials segment researches, develops, manufactures, and sells automotive, industrial, and marine lubricants, as well as grease; engineering plastic, adhesive materials, derivative products, and solvents; electronic materials, such as OLED; asphalt; microbial pesticides, soil amendments, and livestock related materials; and solid state lithium ion battery materials. Its Power and Renewable Energy segment operates thermal power plants; develops and operates renewable energy sources, including solar, wind, and biomass power plants; engages in the supply, wholesale, and retail of electric power; researches, develops, and manufactures CIS thin-film solar modules; and sells solar power systems. The company's Resources segments explores, develops, and produces oil and gas; produces and sells coal and uranium; operates geothermal power plants; and sale of electric power and steam. Idemitsu Kosan Co.,Ltd. was founded in 1911 and is headquartered in Tokyo, Japan.
Full IDKOY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.